Identification of a Chlamydial Protease-like Activity Factor Responsible for the Degradation of Host Transcription Factors

Overview

Journal J Exp Med

Specialties Allergy & Immunology
General Medicine

Date 2001 Apr 17

PMID 11304554

Citations 196

Authors

G Zhong

P Fan

H Ji

F Dong

Y Huang

Affiliations

Soon will be listed here.

Abstract

Microbial pathogens have been selected for the capacity to evade or manipulate host responses in order to survive after infection. Chlamydia, an obligate intracellular pathogen and the causative agent for many human diseases, can escape T lymphocyte immune recognition by degrading host transcription factors required for major histocompatibility complex (MHC) antigen expression. We have now identified a chlamydial protease- or proteasome-like activity factor (CPAF) that is secreted into the host cell cytosol and that is both necessary and sufficient for the degradation of host transcription factors RFX5 and upstream stimulation factor 1 (USF-1). The CPAF gene is highly conserved among chlamydial strains, but has no significant overall homology with other known genes. Thus, CPAF represents a unique secreted protein produced by an obligate intracellular bacterial pathogen to interfere with effective host adaptive immunity.

Citing Articles

Pathogenic and Protective Roles of Neutrophils in Infection.

Wilton Z, Jamus A, Core S, Frietze K Pathogens. 2025; 14(2).

PMID: 40005489 PMC: 11858174. DOI: 10.3390/pathogens14020112.

A TriAdj-Adjuvanted CPAF Protein Vaccine Is Highly Immunogenic in Pigs.

Proctor J, Stadler M, Cortes L, Brodsky D, Poisson L, Gerdts V Vaccines (Basel). 2024; 12(4).

PMID: 38675805 PMC: 11054031. DOI: 10.3390/vaccines12040423.

Requirement of GrgA for infectious progeny production, optimal growth, and efficient plasmid maintenance.

Lu B, Wang Y, Wurihan W, Cheng A, Yeung S, Fondell J mBio. 2023; 15(1):e0203623.

PMID: 38112466 PMC: 10790707. DOI: 10.1128/mbio.02036-23.

Requirement of GrgA for infectious progeny production, optimal growth, and efficient plasmid maintenance.

Lu B, Wang Y, Wurihan W, Cheng A, Yeung S, Fondell J bioRxiv. 2023; .

PMID: 37577610 PMC: 10418237. DOI: 10.1101/2023.08.02.551707.

Tryptophan residue of plasmid-encoded Pgp3 is important for to induce hydrosalpinx in mice.

Huang Y, Wu H, Sun Y, Liu Y Front Microbiol. 2023; 14:1216372.

PMID: 37497542 PMC: 10367112. DOI: 10.3389/fmicb.2023.1216372.

References

Read T, Brunham R, Shen C, Gill S, Heidelberg J, White O . Genome sequences of Chlamydia trachomatis MoPn and Chlamydia pneumoniae AR39. Nucleic Acids Res. 2000; 28(6):1397-406. PMC: 111046. DOI: 10.1093/nar/28.6.1397. View

Shamu C, Story C, Rapoport T, Ploegh H . The pathway of US11-dependent degradation of MHC class I heavy chains involves a ubiquitin-conjugated intermediate. J Cell Biol. 1999; 147(1):45-58. PMC: 2164983. DOI: 10.1083/jcb.147.1.45. View

Tortorella D, Gewurz B, Furman M, Schust D, Ploegh H . Viral subversion of the immune system. Annu Rev Immunol. 2000; 18:861-926. DOI: 10.1146/annurev.immunol.18.1.861. View

Scheffner M, Werness B, Huibregtse J, Levine A, Howley P . The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell. 1990; 63(6):1129-36. DOI: 10.1016/0092-8674(90)90409-8. View

Stephens R . Molecular mimicry and Chlamydia trachomatis infection of eukaryotic cells. Trends Microbiol. 1994; 2(3):99-101. DOI: 10.1016/0966-842x(94)90543-6. View

Beatty W, Morrison R, Byrne G . Persistent chlamydiae: from cell culture to a paradigm for chlamydial pathogenesis. Microbiol Rev. 1994; 58(4):686-99. PMC: 372987. DOI: 10.1128/mr.58.4.686-699.1994. View

Hackstadt T, Scidmore M, Rockey D . Lipid metabolism in Chlamydia trachomatis-infected cells: directed trafficking of Golgi-derived sphingolipids to the chlamydial inclusion. Proc Natl Acad Sci U S A. 1995; 92(11):4877-81. PMC: 41810. DOI: 10.1073/pnas.92.11.4877. View

Zhong G, Castellino F, Romagnoli P, Germain R . Evidence that binding site occupancy is necessary and sufficient for effective major histocompatibility complex (MHC) class II transport through the secretory pathway redefines the primary function of class II-associated invariant chain peptides.... J Exp Med. 1996; 184(5):2061-6. PMC: 2192887. DOI: 10.1084/jem.184.5.2061. View

Rasmussen S, Eckmann L, Quayle A, Shen L, Zhang Y, Anderson D . Secretion of proinflammatory cytokines by epithelial cells in response to Chlamydia infection suggests a central role for epithelial cells in chlamydial pathogenesis. J Clin Invest. 1997; 99(1):77-87. PMC: 507770. DOI: 10.1172/JCI119136. View

10.

Hughes E, Hammond C, Cresswell P . Misfolded major histocompatibility complex class I heavy chains are translocated into the cytoplasm and degraded by the proteasome. Proc Natl Acad Sci U S A. 1997; 94(5):1896-901. PMC: 20014. DOI: 10.1073/pnas.94.5.1896. View

11.

Hackstadt T, Fischer E, Scidmore M, Rockey D, Heinzen R . Origins and functions of the chlamydial inclusion. Trends Microbiol. 1997; 5(7):288-93. DOI: 10.1016/S0966-842X(97)01061-5. View

12.

Wylie J, Hatch G, McClarty G . Host cell phospholipids are trafficked to and then modified by Chlamydia trachomatis. J Bacteriol. 1997; 179(23):7233-42. PMC: 179671. DOI: 10.1128/jb.179.23.7233-7242.1997. View

13.

Zhong G, Reis e Sousa C, Germain R . Production, specificity, and functionality of monoclonal antibodies to specific peptide-major histocompatibility complex class II complexes formed by processing of exogenous protein. Proc Natl Acad Sci U S A. 1998; 94(25):13856-61. PMC: 28397. DOI: 10.1073/pnas.94.25.13856. View

14.

Fan T, Lu H, Hu H, Shi L, McClarty G, Nance D . Inhibition of apoptosis in chlamydia-infected cells: blockade of mitochondrial cytochrome c release and caspase activation. J Exp Med. 1998; 187(4):487-96. PMC: 2212145. DOI: 10.1084/jem.187.4.487. View

15.

Tortorella D, Story C, Huppa J, Wiertz E, Jones T, Bacik I . Dislocation of type I membrane proteins from the ER to the cytosol is sensitive to changes in redox potential. J Cell Biol. 1998; 142(2):365-76. PMC: 2133060. DOI: 10.1083/jcb.142.2.365. View

16.

Stephens R, Kalman S, Lammel C, Fan J, Marathe R, Aravind L . Genome sequence of an obligate intracellular pathogen of humans: Chlamydia trachomatis. Science. 1998; 282(5389):754-9. DOI: 10.1126/science.282.5389.754. View

17.

HATCH T . Chlamydia: old ideas crushed, new mysteries bared. Science. 1998; 282(5389):638-9. DOI: 10.1126/science.282.5389.638. View

18.

Kalman S, Mitchell W, Marathe R, Lammel C, Fan J, HYMAN R . Comparative genomes of Chlamydia pneumoniae and C. trachomatis. Nat Genet. 1999; 21(4):385-9. DOI: 10.1038/7716. View

19.

Askienazy-Elbhar M, Suchet J . Persistent "silent" Chlamydia trachomatis female genital tract infections. Infect Dis Obstet Gynecol. 1999; 7(1-2):31-4. PMC: 1784722. DOI: 10.1155/S1064744999000071. View

20.

Zhong G, Fan T, Liu L . Chlamydia inhibits interferon gamma-inducible major histocompatibility complex class II expression by degradation of upstream stimulatory factor 1. J Exp Med. 1999; 189(12):1931-8. PMC: 2192973. DOI: 10.1084/jem.189.12.1931. View